ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$1039.78
Tradestie Score
43
Market Cap
$46.96B
P/E Ratio
39.5
Revenue Growth
0.6%
Analyst Upside
+12.8%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$548.05
|
$103.64B | 30.8 | 30 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$834.04
|
$63.59B | 19.7 | 34 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$236.22
|
$60.38B | 42.2 | 42 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$374.47
|
$36.81B | 66.2 | 27 | Compare |
|
INSM
Insmed, Inc.
|
$125.77
|
$31.13B | - | 41 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$116.57
|
$24.57B | - | 41 | Compare |
|
GMAB
Genmab A/S ADS
|
$33.45
|
$19.56B | 26.9 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$127.81
|
$16.93B | 16.4 | 41 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$61.31
|
$15.70B | 32.6 | 42 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.16
|
$15.22B | - | 55 | Compare |
More ARGX Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry